Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00640939 · ClinicalTrials.gov registry record · Phase 2
Diclofenac Patch for Treatment of Mild to Moderate Tendonitis or Bursitis
A Phase 2 study, sponsored by Cerimon Pharmaceuticals.
- Completed
- Registry status
- Phase 2
- Development phase
- 308
- Enrollment target
NCT00640939: Completed Phase 2 study, sponsored by Cerimon Pharmaceuticals.
NCT00640939 is a Phase 2 study that has completed, run by Cerimon Pharmaceuticals. The registered enrollment target is 308 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (132% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00640939, a Phase 2 study, has completed, sponsored by Cerimon Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 308 participants
- Enrollment target
Study Summary
The primary purpose of this study is to assess the effectiveness of once daily application of a diclofenac sodium patch to the skin near or over the painful area. In this study, the location being studied will be one of the following: the affected shoulder, elbow, or wrist. The secondary purpose of this study is to assess the safety and tolerability of the diclofenac patch on the subject's skin, in the location being studied.
Interventions
- DRUG Matching Placebo
- DRUG diclofenac sodium
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 308 participants |
| Start Date | 2007-12 |
| Est. Completion | 2008-06 |
| Phase | Phase 2 |
What the finished NCT00640939 record still lists
NCT00640939 is an interventional study that assigns participants to a tested intervention. The registered 308 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (132% higher).
The record links to 0 conditions, and to 2 interventions - of which Matching Placebo is the first listed.
NCT00640939 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00640939 about?
NCT00640939 is a clinical study titled "Diclofenac Patch for Treatment of Mild to Moderate Tendonitis or Bursitis". The primary purpose of this study is to assess the effectiveness of once daily application of a diclofenac sodium patch to the skin near or over the painful area. In this study, the location being studied will be one of the following: the affected shoulder, elbow, or wrist. The secondary purpose of...
What is the current status of trial NCT00640939?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 308 participants. The study started on 2007-12. Estimated completion is 2008-06.
What interventions are being tested in trial NCT00640939?
The interventions under investigation include: Matching Placebo (DRUG), diclofenac sodium (DRUG).
Who is sponsoring clinical trial NCT00640939?
This trial is sponsored by Cerimon Pharmaceuticals, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00640939's enrollment target sits among peer trials
308 163rd of 2000 higher than 1,836 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04162938 · 308 participants · NA
Use of a Patient-Centered Electronic App to Increase ED Patient's Knowledge on HCV to Improve the HCV Care Continuum
- NCT04955795 · 308 participants · NA
Telemedicine for Unhealthy Alcohol Use in Persons Living With HIV Using CETA
- NCT06090539 · 308 participants · Phase 1
A Study to Assess BMS-986458 Alone and in Combination With Anti-lymphoma Agents in Relapsed/Refractory Non-Hodgkin Lymphomas
- NCT06233942 · 308 participants · Phase 1
Phase 1a/1b First-in-Human Study of BG-C9074 Alone and in Combination With Other Anticancer Therapies in Patients With Advanced Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia